|
*100.
Hammer RA, Ochoa A, Fernandez C, Ertan A, Arimura A: Somatostatin
as a mediator of the effect of neurotensin on pentagastrin - stimulated
acid secretion in rats. Peptides, 13:1175-1179, 1992.
*101. Rossowski WJ, Zacharia S, Jiang NJ, Mungan Z, Mills MR, Ertan
A, Coy DH: Galanin: structure-dependent effect on pancreatic
amylase secretion and jejunal strip contraction. Eur J Pharmacol,
240:259-267, 1993.
*102. Ertan A: Profiling colorectal cancer. Annual report
for cancer registry, The Methodist Hospital, 5:18-24,1993.
*103. Ertan A: Medical management of pancreatitis in 1994.
Houston J Gastroenterology, 3:6-10, 1994.
*104. Ertan A, Moody DR: Ulcerative jejunitis with strictures
in celiac sprue. Gastroenterol International, 7:143-144, 1994
*105. Ertan A, Schneider FE: Acute pancreatitis in long-distance
runners. Amer J Gastroenterol, 90:70-71, 1995.
*106. Rabassa AA, Schwartz MR, Ertan A: Alpha-1-antitrypsin
deficiency and chronic pancreatitis. Dig Dis Sc, 40:1997-2001, 1995.
*107. Ertan A, Woods K: Laparoscopic cholecystectomy and
endoscopic retrograde cholangiopancreatography. Houston J Gastroenterology,
5-8, 1995.
*108. Ertan A: Endoscopic therapy of pancreatitis. Turk J
Gastroenterol 6:317-319, 1995.
*109. Ertan A: Immunomodulator therapy of IBD. Turk J Gastroenterol
6:320-322, 1995.
*110. Ertan A, Zimmerman M, Younes M: Esophageal adenocarcinoma
associated with Barrett's esophagus: long-term management with laser
ablation. Amer J Gastroenterology 90:2201-2203, 1995.
*111. Ertan A, Schwartz M, Rabassa A: Alpha-1-antitrypsin
deficiency and chronic pancreatitis. Dig Dis Sc, 41:550-551, 1996
(LTE,response).
*112. Mungan Z, Hammer RA, Akarca US, Komaki G, Ertan A,
Arimura A: Effect of PACAP on gastric acid secretion in rats. Peptides
16:1051-1056, 1996.
*113. Ertan A: Endoscopic pancreatic stenting following pancreatic
papilla dilation without pancreatic sphincterotomy. Turk J Gastroenterol,
8:402-405, 1997.
*114. Younes M, Ertan A, Lechago LV, Somoano J, Lechago J:
Human erythrocyte glucose transporter (glut1) is immunohistochemically
detected as a late event during malignant progression in Barrett's
metaplasia. Cancer Epidemiol Biomarkers Prev, 6:303-305, 1997
*115. Younes M, Ertan A, Lechago LV, Somoano J, Lechago J:
p53 protein accumulation is a specific marker of malignant potential
in Barrett's metaplasia. Dig Dis Sci, 42:697-701, 1997.
*116. Ertan A: Endoscopic management of acute pancreatitis.
Current Practice of Medicine. 2(5):98-101, 1999.
*117. Younes M, Schwartz M, Ertan A, Finnie D, Younes A.
Fas ligand expression in esophageal carcinomas and their lymph node
metastases. Cancer, 88:524-8, 2000.
*118. Younes M, Lechago J, Ertan A, and others: Relationship
between dysplasia, p53 protein accumulation, DNA Ploidy, and Glut1
over expression in Barrett metaplasia. Scand J Gastroenterol. 35:131-7,
2000.
*119. Younes M, Lechago J, Ertan A, Finnie D, Younes A: Decreased
expression of Fas (CD95/AP01) associated with goblet cell metaplasia
in Barrett's esophagus. Hum Pathol. 31:434-438, 2000.
*120 Ertan A: Long-term results after endoscopic pancreatic
stenting without pancreatic papillotomy in acute recurrent pancreatitis
due to pancreas divisum. Gastrointest Endosc. 52:9-14, 2000.
*121. Ertan A Younes M: Barrett's esophagus (Editorial).
Dig Dis Sci, 45:1670-1673, 2000.
*122.
Younes M, Lechago J, Ertan A: Photodynamic therapy and genetic
abnormalities. Gastroenterology, 120: 1065-6, 2001 (LTE).
*123.
Ertan
A: Treatment
of gallstones by extracorporeal shock wave lithotripsy. Am J Gastroenterol,
97: 831-2, 2002.
*124.
Dural TA, Ertan A: Endoscopic retrieval of proximally migrated
dorsal pancreatic duct stent in a patient with pancreas divisium.
Med Sci, 3:65-17, 2002
*125.
Carlson N, Lechago J, Richter J, Sampliner RE, Peterson L, Santella
RM, Go |
